Effect of Addition of Adjuvant Paclitaxel on Radiotherapy Delivery and Locoregional Control of Node-Positive Breast Cancer: Cancer and Leukemia Group B 9344 The study included 1,034 patients with ...

Invasive lobular carcinoma (ILC) accounts for up to 15% of all invasive breast cancers and has long been recognized as being different from infiltrating ductal carcinoma (IDC). Now, a genomic ...

Beliefs on Causes of Cancer in the General Population, and the Association With Risk Perception and Lifestyle in a Multiethnic Setting This study included a training (1,890 patients) and a validation ...

Sichun Yang, PhD, a member of Case CCC's Molecular Oncology Program, and Alberto Montero, MD, a Developmental Therapeutics Program member, are looking for patient advocates for a follow-up study to ...

Dr. Melvin Silverstein answers the question: 'What's Invasive Ductal Carcinoma?' — -- Question: What is invasive ductal carcinoma? Answer: Invasive ductal carcinoma is the most common type of ...

A woman who was first diagnosed with cancer in 2008 at the age of 37 fought it off but was told nine years ago that the ...

The Breast International Group (BIG) 1-98 study evaluated adjuvant endocrine therapy in postmenopausal women who had hormone receptor-positive early-stage breast cancer. The study participants were ...

The SNMMI Mars Shot Research Fund is pleased to announce that Randy Yeh, MD, a radiologist and nuclear medicine physician at Mount Sinai Health System, associate professor of radiology, and chief of ...